Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 4/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16188798 | 0.82 | CYP1A2 (0.44) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL14525496 | 0.81 | CYP1A2 (0.39) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL12227988 | 0.80 | CYP1A2 (0.42) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL27286459 | 0.78 | CYP1A2 (0.46) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL14525479 | 0.74 | CYP1A2 (0.44) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL20802475 | 0.73 | CYP1A2 (0.39) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL19153759 | 0.71 | CYP1A2 (0.46) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL20803062 | 0.71 | PTPN11 (0.31) | ESR1ESR2 | |
| SCHEMBL17787997 | 0.71 | LMNA (0.50) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL14444114 | 0.69 | CYP1A2 (0.50) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20190078019-A1 | COMPOUND HAVING NAPHTHALENE RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-03-14 | — | — | US | disclosed |
| EP-3453697-A1 | COMPOUND HAVING NAPHTHALENE RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | PYM1, CXCR1, CPNE4 | CYP1A2 179/4885CYP2A6 2002/4885LMNA 1099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.